Pain resulting from osteoporotic fractures should be treated with a multimodal approach that includes pharmacological and nonpharmacological strategies.
Epidural Steroid Injections Associated With Decreased Bone Mineral Density, Increased Risk for Vertebral FractureJanuary 25, 2018
Epidural steroid injections may be associated with reduced bone mineral density and an increased risk for vertebral fracture.
Clinicians who treat osteoporotic fractures should prescribe anti-osteoporotic drugs to prevent secondary vertebral and non-vertebral fractures.
The FDA has approved abaloparatide injection for postmenopausal women with osteoporosis at an increased risk of fracture
Patients with multiple sclerosis (MS) have lower bone mineral density and greater rates of osteoporosis than healthy controls.
Fewer than 1 in 4 women receive recommended assessment or treatment of osteoporosis within 1 year after hip fracture.
In addition to hip fractures, fractures of the spine, shoulder, wrist, or clavicle can lead to a significantly increased risk of death.
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness